Trial Profile
A Multicenter, Open-lable, Observational, Prospective, Post-marketing Surveillance Study to Evaluate the Efficacy and Safety of Modified-release Tacrolimus in Japanese Renal Transplant Recipients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 30 Nov 2015 New trial record